Exclusive

Publication

Byline

Femina Miss India 2026 participants arrive at KIIT campus to rousing reception

BHUBANESWAR, April 13 -- The 30 state winners from across the country who have qualified for the 61st Femina Miss India event being held at KIIT on April 18, arrived in the campus today to a rousing r... Read More


TOPS set for a revamp

India, April 13 -- The Target Olympic Podium Scheme (TOPS) is set for a revamp, bringing more athletes and disciplines under the programme. Sports Minister Mansukh Mandaviya said on Monday that a fres... Read More


Laxmi Organic CFO Mahadeo Karnik resigns

Mumbai, April 13 -- He will be relieved from his duties at the close of business hours on 13 April 2026. The board has expressed its appreciation for his contributions during his tenure. Following th... Read More


Presidential favourite Wadagni elected in Benin with over 94 percent of votes

France, April 13 -- The electoral commission published the preliminary tally overnight Monday to Tuesday, though it has not yet issued final official results. Sacca Lafia, head of the country's indep... Read More


Rs.12-crore stock scam: Supreme Court AOR warns of rising fraud tactics; 5 tips to stay safe

New Delhi, April 13 -- The assurance of quick wealth continues to lure even the most educated citizens into elaborate financial traps. In a shocking case from Pune, a 75-year-old doctor suffered a fin... Read More


Lafarge, it's former executives convicted of financing terrorism

Nigeria, April 13 -- A Paris court on Monday convicted French cement giant Lafarge and eight former executives of financing terrorism, ruling they paid jihadist groups millions to keep a Syrian plant ... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More